Giles Lisa M. 4
4 · Milestone Pharmaceuticals Inc. · Filed Jun 12, 2025
Insider Transaction Report
Form 4
Giles Lisa M.
Director
Transactions
- Award
Stock Option (right to buy)
2025-06-10+40,000→ 40,000 totalExercise: $1.75Exp: 2035-06-10→ Common Stock (40,000 underlying)
Footnotes (1)
- [F1]This option will vest in twelve (12) equal monthly installments, beginning on July 10, 2025, provided that the option will in any case be fully vested on the date of next annual meeting of the stockholders of the Issuer, subject to the Reporting Person continuing to provide service through each such vesting date.